Correction to: Scientific Reports https://doi.org/10.1038/s41598-018-32210-x, published online 26 September 2018

The original version of this Article contained typographical errors, where the unit ‘ng/ml’ was incorrectly given as ‘pg/ml’. As a result, in the Abstract,

“The cut-off value of H-FABP, 4.143 pg/mL, was determined using receiver operating characteristic curves.”

now reads:

“The cut-off value of H-FABP, 4.143 ng/mL, was determined using receiver operating characteristic curves.”

In the Results section under subheading ‘Patients’,

“The cut-off value of H-FABP (4.143 pg/mL) was determined by receiver operating characteristic curves (ROC) curve analysis (Fig. 1) between the patients with and without CV events from the blood sample obtained at enrollment.”

now reads:

“The cut-off value of H-FABP (4.143 ng/mL) was determined by receiver operating characteristic curves (ROC) curve analysis (Fig. 1) between the patients with and without CV events from the blood sample obtained at enrollment.”

In the Discussion section,

“This study is the first prospective cohort study to demonstrate that a higher serum H-FABP level (≧4.143 pg/mL) is an independent predictor for CV events, particularly for cardio- and cerebrovascular death and acute heart failure-related hospitalizations in patients with SCHD.”

now reads:

“This study is the first prospective cohort study to demonstrate that a higher serum H-FABP level (≧4.143 ng/mL) is an independent predictor for CV events, particularly for cardio- and cerebrovascular death and acute heart failure-related hospitalizations in patients with SCHD.”

In Table 2, the column headings ‘H-FABP < 4.143 pg/mL’ and ‘H-FABP ≧ 4.143 pg/mL’ have been corrected to ‘H-FABP < 4.143 ng/mL’ and ‘H-FABP ≧ 4.143 ng/mL’, respectively.

In Table 3, the column headings ‘H-FABP <4.143pg/mL, (n=843)’ and ‘H-FABP ≧4.143pg/mL, (n=228)’ have been corrected to ‘H-FABP <4.143ng/mL, (n=843)’ and ‘H-FABP ≧4.143ng/mL, (n=228)’, respectively.

In the legend of Figure 2,

“Kaplan–Meier survival curves analysis showing total cardiovascular (CV) event-free rate (a), CV or cerebrovascular death-free rate (b), acute heart failure hospitalization-free rate (c), and total CV event-free rate except for angina-related hospitalization (d) in patients with serum H-FABP ≧4.143 pg/mL and H-FABP <4.143 pg/mL (all p < 0.001).”

now reads:

“Kaplan–Meier survival curves analysis showing total cardiovascular (CV) event-free rate (a), CV or cerebrovascular death-free rate (b), acute heart failure hospitalization-free rate (c), and total CV event-free rate except for angina-related hospitalization (d) in patients with serum H-FABP ≧4.143 ng/mL and H-FABP <4.143 ng/mL (all p < 0.001).”

In addition, the original version of this Article contained typographical errors, where the unit ‘g/dL’ was incorrectly given as ‘mg/dL’. As a result, in Table 2, the row heading ‘Hemoglobin, mg/dL’ has been corrected to ‘Hemoglobin, g/dL’.

These errors have now been corrected in the HTML and PDF versions of the Article.